ClinicalTrials.gg
Not yet recruitingNCT07945080Updated Nov 18, 2026

Health Outcomes of CAPABLE in Permanent Supportive Housing

An interventional study of Community Aging in Place-Advancing Better Living for Elders in Functional Limitations, Activities of Daily Living and Aging, sponsored by University of Southern California. Not yet recruiting at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Southern California · Not applicable, Interventional, and Health services research

How we know

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
634
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 134 studies in Patient Acceptance of Health Care with a site in United States — 24 open to participants now, 35 under way, 1 of them phase 3. Patient Acceptance of Health Care · United States.

Planned enrollment
28th of 109
634 · median 264
Started
2027
the only one that year
No phase
100 of 134
21 open now
Primary completion
2029-08
later than 30 of 34 live
Registered
134th of 134
by date

Among the 134 studies in Patient Acceptance of Health Care with a site in United States, this one is the 28th largest by planned enrollment of the 109 interventional ones that give a count, is the only one that started in 2027, is one of 100 with no phase, reaches primary completion later than 30 of the 34 other live ones, and was the 134th registered.

Patient Acceptance of Health Care

309 studies on the registry are indexed under Patient Acceptance of Health Care; 54 are open to participants now.

Browse Patient Acceptance of Health Care studies →

Open to participants now

24 of the 134 studies in Patient Acceptance of Health Care with a site in United States are open now. Recruiting first, the newest first:

19 more — sign in →

All 24 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 34 Patient Acceptance of Health Care studies recruiting now, 22 (65%) set no upper age limit and 9 (26%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 134 studies in Patient Acceptance of Health Care with a site in United States, or all of them as a file.
02

Study summary

This study will evaluate whether Community Aging in Place-Advancing Better Living for Elders (CAPABLE) improves daily functioning among adults aged 45 years and older who live in permanent supportive housing and have difficulty performing everyday activities.

Participants will be randomly assigned to receive either CAPABLE in addition to their usual services or usual services alone. CAPABLE is a person-directed, home-based program delivered by an occupational therapist and a registered nurse. Participants assigned to CAPABLE may receive up to 10 home visits over approximately six months, including up to six occupational therapy visits and four nursing visits. Assistive devices and minor home modifications may also be provided based on each participant's goals and needs.

The study will enroll approximately 634 participants in Los Angeles County. Researchers will assess participants at enrollment and at 3, 6, 9, and 12 months. The main outcomes are participants' ability to perform activities of daily living and instrumental activities of daily living. The study will also examine health-related quality of life, health care use, housing stability, and the cost-effectiveness of CAPABLE.

Read the detailed description

This randomized effectiveness trial will examine the effectiveness and cost-effectiveness of CAPABLE when delivered to adults living in permanent supportive housing. CAPABLE is a person-directed intervention designed to address functional limitations by integrating occupational therapy, nursing, assistive devices, and minor home modifications.

Approximately 634 participants will be randomly assigned in a 1:1 ratio to the CAPABLE intervention group or the usual-care control group. Participants assigned to CAPABLE will receive the intervention in addition to the health and supportive services normally available to them. The intervention may include up to six occupational therapy visits and four registered nursing visits over approximately six months. The occupational therapist and nurse will work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services will be provided when appropriate. Participants assigned to the control group will continue to receive their usual services.

Study assessments will occur at baseline and at 3, 6, 9, and 12 months. Full outcome assessments will be conducted at baseline, 6 months, and 12 months, with shorter assessments of health care utilization and health-related quality of life at 3 and 9 months. The primary outcomes are limitations in activities of daily living and instrumental activities of daily living. Additional outcomes include health-related quality of life, health care utilization, housing stability, and intervention costs.

Outcome assessors will be masked to participants' treatment assignments. The economic evaluation will compare intervention costs with changes in health-related quality of life and health care utilization to estimate the cost-effectiveness of CAPABLE relative to usual care.

03

Conditions studied

  • Functional Limitations
  • Activities of Daily Living
  • Aging

Keywords

  • CAPABLE
  • Permanent supportive housing
  • Instrumental activities of daily living
  • Independent living
  • Occupational therapy
  • Home-based care
  • Housing stability
  • Health-related quality of life
  • Health care utilization
  • Cost-effectiveness
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able and willing to provide
  • Client of the Los Angeles County Department of Health Services
  • Living in permanent supportive housing
  • Age 45 years or older
  • Cognitively intact or experiencing only mild cognitive impairment
  • Proficient in English or Spanish
  • Reports some or a lot of difficulty performing at least one activity of daily living or instrumental activity of daily living

Exclusion criteria

Exclusion Criteria:

  • Does not meet one or more inclusion criteria
  • Unwilling or unable to provide
  • Withdraws consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
634 participants (estimated)

Study arms

  • Experimental
    CAPABLE

    Participants assigned to this arm will receive CAPABLE in addition to their usual health and supportive services. CAPABLE is a person-directed, home-based intervention delivered over approximately six months and may include up to six occupational therapy visits and four registered nursing visits. Assistive devices, minor home modifications, and coordination with existing services may be provided based on each participant's goals and needs.

    Behavioral: Community Aging in Place-Advancing Better Living for Elders

  • No intervention
    Usual Care

    Participants assigned to this arm will continue to receive the health and supportive services normally available to them and will not receive the CAPABLE intervention during the study.

Interventions

  • BehavioralCommunity Aging in Place-Advancing Better Living for Elders

    CAPABLE is a person-directed, home-based behavioral intervention designed to improve participants' ability to perform everyday activities. The intervention is delivered over approximately six months and may include up to six visits from an occupational therapist and four visits from a registered nurse. The occupational therapist and nurse work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services may be provided as appropriate based on each participant's goals and needs.

06

What researchers measure

Primary outcomes

  1. Change in Activities of Daily Living Limitations

    Activities of daily living will be assessed using an 8-item scale measuring difficulty with basic daily activities. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

    Time frame: Baseline, 6 months, and 12 months

  2. Change in Instrumental Activities of Daily Living Limitations

    Instrumental activities of daily living will be assessed using the 8-item Brief Instrumental Functioning Scale. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

    Time frame: Baseline, 6 months, and 12 months

Secondary outcomes

  1. Quality-Adjusted Life Years

    Health-related quality of life will be measured using the five-item EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Responses will be converted to health-state utility values and used to calculate quality-adjusted life years over the 12-month follow-up period. Higher quality-adjusted life years indicate better health outcomes.

    Time frame: Baseline and 3, 6, 9, and 12 months

  2. Health Care Utilization

    Health care utilization during the preceding three months will be assessed using the 12-item UCSD Healthcare Utilization Questionnaire. Participants will report their use of inpatient hospital care, surgery, nursing home care, emergency department care, ambulance services, outpatient health care, home care, telephone or online health care, prescription medications, and over-the-counter medications. Utilization will be compared between study arms and used to estimate health care costs.

    Time frame: Baseline and 3, 6, 9, and 12 months

  3. Incremental Cost-Effectiveness of CAPABLE

    Incremental cost-effectiveness ratios will compare CAPABLE with usual care. Ratios will be calculated by dividing the difference between study arms in intervention and health care costs by the corresponding differences in activities of daily living limitations, instrumental activities of daily living limitations, and quality-adjusted life years. Lower costs per unit of improvement indicate greater cost-effectiveness.

    Time frame: From baseline through 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — A deidentified quantitative individual participant dataset will be shared. The study protocol, survey instruments, and data dictionary will also be made available to facilitate interpretation and reuse of the data. The dataset and associated documentation will be deposited in the National Archive of Computerized Data on Aging (NACDA), which is part of ICPSR.

Supporting information: Study protocol

Time frame: The IPD and supporting information will become available following completion of the planned study analyses and no later than August 31, 2031. Materials deposited in NACDA will remain available indefinitely.

Access criteria: Researchers will be able to access the deidentified individual participant dataset and supporting documentation through NACDA within ICPSR at no charge. Users must agree to the repository's terms of use, including limiting use to research or statistical purposes, not attempting to identify participants, not redistributing downloaded data, and properly citing the dataset.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2027; primary completion for Aug 2029, 29 months later.

Of 151 non-industry interventional studies with no phase under Patient Acceptance of Health Care, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's planned 29 months is above that.

Counting every sponsor, half of 154 studies reached it within 19 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 18, 2026
StartEst.
Mar 1, 2027
Primary completionEst.
Aug 31, 2029
CompletionEst.
Aug 31, 2030
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945080
Responsible party
Benjamin F. Henwood (Professor, University of Southern California) — Principal investigator
First posted
Nov 18, 2026
Start date
Mar 1, 2027 (estimated)
Primary completion
Aug 31, 2029 (estimated)
Completion
Aug 31, 2030 (estimated)
Last update
Nov 18, 2026

Study contacts

Benjamin F Henwood, PhD, MSW, MA
Contact
bhenwood@usc.edu
213-821-0496

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion